In France, cannabis consumption is illegal. The health impact of its increasing use and higher tetrahydrocannabinol (THC) concentrations is still poorly documented, particularly that of unintentional pediatric intoxications. We sought to evaluate the French national trend of admissions for unintentional cannabis intoxication in children over an 11-year period (2004-2014).
France, where cannabis is illegal, is the highest drug-consuming country in Europe. 1 Users are mainly young adults and teenagers aged 15 to 16 years old with rates of 22% and 39%, respectively. Among ninth graders, this rate was 24% among girls and 28% among boys in 2014. 2, 3 Whereas the herbal cannabis market changes with increased French production, most cannabis resin is imported from Morocco via Spain by air or sea and moves through France toward the Netherlands and Northern Europe by road using "go fast or go slow" vehicles. The resin form has changed to smaller, olive-shaped pellets rather than traditional 250 g bars. 1 Another major change is increased Δ9-tetrahydrocannabinol (THC) concentrations in both marijuana and hashish (9.3% in 2004 and 20.7% in 2014 in France). 4 The health impact of these trends remains poorly documented, particularly that of the evolution of unintentional intoxication in young children.
The primary objective was to analyze the national evolution of pediatric admissions for unintentional cannabis intoxication in the main French pediatric emergency departments (PEDs) over an 11-year period (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) . The secondary objectives were to detail clinical presentations and analyze the evolution of severe intoxications (coma, respiratory depression, and apnea) and the resulting social and legal measures.
MethODs study Design
This was a national, multicenter, retrospective, observational study of a pediatric cohort.
setting and study Participants
All children <6 years of age who were admitted with proven cannabis intoxication (compatible clinical symptoms and positive toxicological screening results) in a tertiary-level PED during the reference period were eligible. Compatible clinical symptoms that defined "intoxicated" children were any acute neurologic symptom(s) (eg, drowsiness, ataxia, hypo-or hypertonia, seizures, comatose status, altered consciousness, agitation, euphoria, and/or mydriasis) occurring in a previously healthy, afebrile toddler with no antecedents. Patients >6 years of age, asymptomatic patients (those who were exposed but not intoxicated), and those with suspected but unproven cannabis intoxications were not included. 
ethical and Regulatory considerations
The data recorded during this research were subject to electronic processing at the Toulouse University Hospital PED in accordance with law 
ResuLts

Descriptive analysis
Twenty-four PEDs (80% of national PEDs) in 20 French districts and 21 regions took part in the study. During the study period, 235 children matching the inclusion criteria were admitted. Seventy-one percent were aged 18 months old or younger (Fig 1) . Tables 2  and 3 and were predominantly neurologic symptoms (86%). Eighty-three (35%) children had at least 1 severity criteria. Fifty-three percent of all children with comas were admitted during 2014 (Fig 3) . Fourteen patients were diagnosed with respiratory failure, and 8 required assisted ventilation for 24 hours or less. Basic metabolic panel blood tests that were performed on 178 patients (76%) revealed abnormalities (n = 40). These included high blood sugar levels (n = 14), hyponatremia (≤130 mmol/L) (n = 8), metabolic acidosis (n = 5), and functional kidney failure (n = 5). Additional procedures included the following: electrocardiograms (n = 63), head computed tomography scans (n = 39), abdominal ultrasounds (n = 39), lumbar puncture (n = 24), and EEGs (n = 24). In addition to cannabis detection, blood and/or urine toxicological screenings (for benzodiazepines, barbiturates, opiates, amphetamines, methamphetamine, cocaine, buprenorphine, norbuprenorphine, methadone, codeine, lysergic acid diethylamide, ethanol, tricyclic antidepressants, paracetamol, and tramadol) were performed in 205 cases. Eight other molecules were isolated in 8 children (4%) ( Table 4) . None of these patients required assisted ventilation. Paracetamol was allegedly being given to treat hyperthermia (n = 2). Benzodiazepines were detected in children who had received diazepam to stop seizures. Most of the children were hospitalized (88%), of whom 27 were in a resuscitation unit or ICU. Parental cannabis consumption was indicated in 146 cases (62%), and 72% declared to be regular users. Social or legal measures included a referral to CPS for 162 cases, a written report for special concern for 39 children, 5 children were placed in foster care by court order, and 4 families were subject to a complaint filed with a police department. 
comparative analysis
DIscussIOn
The evolution of unintentional pediatric cannabis intoxications is remarkable because of increased admissions throughout the country and an increase in severe presentations (Fig 3) . 12 European data on cannabis potency are based on forensic analysis of seized materials. This is not necessarily representative of the market, especially in countries with significant domestic cultivation (eg, the Netherlands). 13 Detailed data on cannabis product potency have been studied in the Netherlands, the United Kingdom, France, the United States, 14 and Australia. 15 In the Netherlands, the THC content of resin is higher than herbal products of the same origin (local or imported), and Dutch products are more potent than imported ones (local resin 29.6% vs 14.3%). 13, 16 In the United Kingdom, cannabis seized by law enforcement showed no change in the mean potency of resin (5.9%) or imported herbs (8.5%) in 2008. 17 In the United States, ElSohly et al, 14 focusing on seized products, published a mean cannabis potency of 12%. In Australia, Swift et al 15 found the same evolution toward a higher potency of herbal cannabis (a mean THC content of 14.9%). Cannabis decriminalization also seems to contribute to the progression of moderate to severe pediatric intoxications. In the United States, these clinical forms are significantly more represented in states where cannabis has been decriminalized. 18 -21 In these states, the ingestion of food products containing cannabis is of concern. 22 The risk of exposure is high because of attractive packaging and naming that is phonetically similar to the original candy (eg, "Beef-Kat" or "Oeo"). 10, 22 -24 In France, the ingestion of resin sticks or balls is the main source of intoxication. 6, 8, 9, 25 -29 Intoxication in infants through passive inhalation has also been described. 30 The main compounds in cannabis have a plasma peak between 1 hour for inhalation and 3 to 4 hours for ingestion. The effects last between 6 and 24 hours. 30 More prolonged neurologic effects have been published. 31 The comparison of the evolution of clinical manifestations of pediatric intoxications presented by Spadari et al 6 or Cao et al 8 to the current study indicates a higher proportion of neurologic and cardiovascular symptoms in our cohort (Table 2) . We believe this difference could be related to an elevated resin potency. The occurrence of seizures was described by several authors. [6] [7] [8] 25 The proconvulsive effect of cannabis is not unanimous. Some authors advocate the opposite effect because of the physiopathology of cannabinoids and the capacity to reduce the release of neurotransmitters, such as γ-aminobutyric acid or glutamate, and therefore neuronal excitability. 31, 32 Seizures would be related to possible adulterants of the resin (eg, anticholinergic substances, cocaine, or methamphetamine) or a concomitant ingestion of another toxin instead. 33 The adulteration of cannabis resin was previously alleged. Moroccan hashish is cut mainly with a range of inert or active substances (eg, soil, henna, paraffin or bee wax, glue, licorice, or coffee). 34 There is little data on adulterants in cannabis resin, and the existing data are controversial. its presence is inconsistent (Table 2) . This inconsistency explains the diagnostic uncertainty in cases of coma and the use of additional tests (eg, head computed tomography scans, lumbar puncture, EEGs, and metabolic tests). 35 Cardiovascular symptoms are the result of the stimulation of type 1 cannabinoid receptors located in the heart. This stimulation generates an orthostatic and parasympathetic imbalance and the activation of the sympathetic system and potential blockage of the parasympathetic system. 36 -38 These transitory manifestations, which are dominated by sinus tachycardia, do not usually require any specific therapy. 38, 39 Adulterants should also be considered in the presence of severe cardiovascular manifestations (eg, myocardial infarction, coronary syndrome, and rhythm disorder). Hyponatremia may be explained by the direct effect of THC on the hypothalamic-pituitary axis (the release of vasopressin) 23 or the effects of an adulterant, such as methamphetamine. 40 In our cohort, 6 of 8 patients with hyponatremia were screened. Results were negative for methamphetamine.
The increase in severe pediatric patients admitted to a pediatric intensive care or resuscitation unit was identified in France by Le Garrec et al. 35 Because of the current prevalence of cannabis intoxication in young children, this diagnosis should be considered when an afebrile comatose child is admitted to a French emergency unit. 29, 35 Given the increased frequency, it could also be assumed that physicians investigated cannabis intoxication more often, and this may have contributed to the increase in prevalence in the last 2 years.
No pediatric deaths because of cannabis intoxication have been reported. The systematic postmortem toxicological detection in a pediatric cohort of 730 children <19 years of age showed that 38% tested positive for toxic drugs or medications, but none of them were for cannabis. 41 The variation in social measures accounts for the difficulty (in legal terms) of such cases in which the intoxicated person is not the user of the illicit drug but is vulnerable and subjected to the environment and parental or caregiver supervision. 42 Because of the retrospective character of the study, some data available were insufficient (eg, parental cannabis consumption). Some children could have been admitted to non-PEDs, but usually (because of the alarming clinical presentation), they are transferred to the nearest regional PED. Extensive toxicological screening was not performed for all children. Cointoxications could have been underestimated for 30 patients. Cointoxication was detected in 4% (n = 8) of the screened patients (n = 205), making the risk of underestimation low for the unscreened patients. Most molecules known to produce false-positives for THC in urinalysis were not taken by our pediatric population (eg, dronabinol, efavirenz, naproxen, pantoprazole, and tolmetin). Concerning ibuprofen, a falsepositive result for cannabinoids in urine tests has been shown only in 2 of 24 adult patients with chronic treatment. 43 Niflumic acid can cause false-positive urine test results in some commercial immunoassays for cannabinoids, 44 but it is not recommended in France for fever management. The risk of falsepositive urine detection because of niflumic acid use was therefore limited in nonscreened patients.
cOncLusIOns
In France, the increase of cannabisrelated PED admissions seems obviously linked to changing consumption trends and a higher potency of the predominant form on the market (hashish). In countries where marijuana has been decriminalized, this increase is related to greater availability and the growing lucrative market of edible products containing marijuana. In countries where cannabis potency has remained low, this pediatric health issue has not been reported. In the Netherlands, cannabis has been culturally smoked in coffee shops for some time. 
